Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Mohammad Hossein, Harirchian"'
Autor:
Melika Jameie, Mehdi Azizmohammad Looha, Zahra Ebadi, Mobina Amanollahi, Kiana Amani, Fatemeh Nobahari, Alireza Abdollahi, Marziyeh Mousavi, Bahareh Pourghaz, Mohammad Hossein Harirchian
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-15 (2024)
Abstract Background To investigate the safety (adverse events [AEs] and post-vaccination multiple sclerosis [MS] activity within 6 weeks), clinical efficacy (protection against coronavirus disease 2019 [COVID-19]), and vaccine-induced humoral immunog
Externí odkaz:
https://doaj.org/article/a034fce2b63f4702a019735fb610c109
Autor:
Zahra Salehi, Mohammad Mehdi Naghizadeh, Sajjad Ghane Ezabadi, Azadeh Ebrahimitirtashi, Naghmeh Abbasi Kasbi, Faezeh Khodaie, Shahram Aliyari, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Seyed Massood Nabavi, Samaneh Hosseini, Nazanin Razazian, Vahid Shaygannejad, Nastaran Majdi-Nasab, Mohammad Hossein Harirchian, Asghar Bayati, Hoda Kamali, Nahid Hosseni Nejad Mir, Nahid Beladi Moghadam, Maryam Poursadeghfard, Hossein Mozhdehipanah, Nazanin Jalali, Mohammad Ali Nahayati, Fardin Faraji, Naser Kamyari, Mohammad Ali Sahraian, Zhila Maghbooli, Sharareh Eskandarieh
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32946- (2024)
Background: The rising prevalence of familial multiple sclerosis (MS) in Iran has spurred interest in the potential impact of parental consanguinity on the risk of developing the disease. This study aims to aggregate current knowledge on parental con
Externí odkaz:
https://doaj.org/article/e85d4a5095a544dca987d745e6095cf8
Autor:
Kimiya Rastegari, Manijhe Mokhtari-Dizaji, Mohammad Hossein Harirchian, Hassan Hashemi, Niloofar Ayoobi Yazdi, Hazhir Saberi
Publikováno v:
Ultrasonography, Vol 42, Iss 1, Pp 100-110 (2023)
Purpose Investigations of the hemodynamic changes of the venous system in patients with multiple sclerosis (MS) have shown contradictory results. Herein, the biomechanical parameters of the internal jugular vein (IJV) and common carotid artery (CCA)
Externí odkaz:
https://doaj.org/article/739dd47cc7344e438157d06367b7b447
Autor:
Mahin Hosseininejad, Elaheh Kabir-Mokamelkhah, Mohammad Hossein Harirchian, Razieh Sirous, Saber Mohammadi, Samaneh Kabiri
Publikováno v:
Türk Nöroloji Dergisi, Vol 28, Iss 4, Pp 223-228 (2022)
Objective: Multiple sclerosis (MS) is a chronic disease of the central nervous system that is usually diagnosed at the working-age (20-45 years) and can negatively affect patients' job performance and ability in work. The purpose of this study was to
Externí odkaz:
https://doaj.org/article/8be491e16bb545d8bc19f0e09c333720
Publikováno v:
Journal of Modern Rehabilitation, Vol 17, Iss 4 (2023)
Introduction: Multiple sclerosis (MS) is one of the most common disabling neurologic diseases worldwide. Although occupational performance problems are reported in many people living with MS, there is little information on these problems in people wi
Externí odkaz:
https://doaj.org/article/35077b3c36d346fb963a9638e8e397a1
Autor:
Majid Eydi-Baygi, Abdolaziz Aflakseir, Mehdi Imani, Mohammad Ali Goodarzi, Mohammad Hossein Harirchian
Publikováno v:
Caspian Journal of Internal Medicine, Vol 13, Iss 3, Pp 607-616 (2022)
Background: MS is a demyelinating disease that can result in significant disability. Along with physical complications, this disease is associated with significant psychological complications, including cognitive decline. Therefore, this study aimed
Externí odkaz:
https://doaj.org/article/cc15a71b88ca448dae6ab68ecd60573c
Autor:
Masood Najafi, Sharareh Eskandarieh, Nasim Rezaeemanesh, Hora Heydari, Marzieh Moosavi, Mohammad Hossein Harirchian
Publikováno v:
Caspian Journal of Neurological Sciences, Vol 8, Iss 2, Pp 98-103 (2022)
Background: Coronavirus Disease 2019 (COVID-19) is a highly contagious disease that resulted in 4533645 deaths until September first, 2021. Multiple Sclerosis (MS) patients receive immunosuppressive drugs. Thus, there is a concern that these drugs wi
Externí odkaz:
https://doaj.org/article/70870c9360564153b5a80fea1d3ee138
Autor:
Zahra Salehi, Amir Almasi-Hashiani, Mohammad Ali Sahraian, Fereshteh Ashtari, Seyed Mohammad Baghbanian, Nazanin Razazian, Abdorreza Naser Moghadasi, Asghar Bayati, Amir Reza Azimi, Nahid Beladimoghadam, Mohammad Hossein Harirchian, Maryam Poursadeghfard, Samira Navardi, Reza Shirkoohi, Hora Heidari, Mehran Ghaffari, Sharareh Eskandarieh
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Admittedly, little is known about the epidemiological signatures of familial multiple sclerosis (FMS) in different geographical regions of Iran. Objective To determine the epidemiology and the risk of FMS incidence in several prov
Externí odkaz:
https://doaj.org/article/1bffdeddea84491abec3c5c661764af2
Autor:
Nasser Samadzadehaghdam, Bahador Makkiabadi, Ehsan Eqlimi, Fahimeh Mohagheghian, Hassan Khajehpoor, Mohammad Hossein Harirchian
Publikováno v:
Journal of Biomedical Physics and Engineering, Vol 11, Iss 2, Pp 205-214 (2021)
Background: Brain source imaging based on electroencephalogram (EEG) data aims to recover the neuron populations’ activity producing the scalp potentials. This procedure is known as the EEG inverse problem. Recently, beamformers have gained a lot o
Externí odkaz:
https://doaj.org/article/581ab4b0cca94a75bdd2ac2eb1a0cac3
Autor:
Rozita Doosti, Abdorreza Naser Moghadasi, Amir Reza Azimi, Shahrokh Karbalai Saleh, Masoud Etemadifar, Vahid Shaygannejad, Fereshteh Ashtari, Mohammad Hossein Harirchian, Bahaadin Siroos, Hormoz Ayramloo, Nastaran Majdinasab, Seyyed Mohammad Masood Hojjati, Nabiollah Asghari, Seyed Mohammad Baghbanian, Hamed Cheraghmakani, Mahmoud Abedini, Behnaz Sedighi, Negar Mohseni Abbas abadi, Maedeh Ghasemitabar, Sara Talebianpour, Tohid Babayi Daylari, Vahid Dana, Neda Ghaleh noie, Mohammad Ali Sahraian
Publikováno v:
Caspian Journal of Internal Medicine, Vol 12, Iss 3, Pp 263-274 (2021)
Background: Fingolimod was the first oral therapy approved for treating relapsing-remitting multiple sclerosis (RRMS) in 2010. This open-label study evaluated the safety and efficacy of fingolideR, 0.5 mg in Iranian MS patients during one-year follow
Externí odkaz:
https://doaj.org/article/2454aeef27884e99a3cdacef22aebeba